Company news, research breakthroughs, and major announcements across industries.

Home/Science

Science |Okomera

Okomera Announces a Commercial Agreement With Servier to Use Its Tumor Miniaturization Technology for Cancer Research

Okomera_Primary_Logo%4010x.jpg
Okomera_Primary_Logo%4010x.jpg

Okomera, a TechBio company pioneering personalized cancer care through a proprietary technology platform combining tumor mini-avatars, microfluidics, and AI-powered imaging, today announced the signing of a commercial agreement with Servier, an independent international pharmaceutical group, to use its technology in the development of new cancer treatments. With more than 90% of oncology drug candidates never reaching the market, identifying early on the therapeutic appr...

  • PublishedOctober 21, 2026 · 2:00 AM
  • LocationPARIS
  • IndustryScience
  • LanguageEN

Published by Business Wire. Read the original announcement for the full release.

Read the full announcement →

Latest from leading organizations

Explore recent announcements by organization